These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1898613)

  • 1. Modulation of Mycobacterium avium growth in murine macrophages: reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4.
    Denis M; Gregg EO
    J Leukoc Biol; 1991 Jan; 49(1):65-72. PubMed ID: 1898613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.
    Appelberg R; Orme IM
    Immunology; 1993 Nov; 80(3):352-9. PubMed ID: 8288311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.
    Denis M; Gregg EO
    Immunology; 1990 Sep; 71(1):139-41. PubMed ID: 2120128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ability of human monocytes and macrophages to control the intracellular growth of Mycobacterium avium and Mycobacterium tuberculosis: effect of interferon-gamma and indomethacin.
    Carvalho de Sousa JP; Rastogi N
    FEMS Microbiol Immunol; 1992 Aug; 4(6):329-34. PubMed ID: 1524839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium.
    Denis M; Gregg EO
    Can J Microbiol; 1991 Jun; 37(6):479-83. PubMed ID: 1913352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    Denis M
    J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin on the modulation of Mycobacterium avium growth in human macrophages by interferon gamma, retinoic acid and 1,25(OH)2-vitamin D3.
    Carvalho de Sousa JP; Bachelet M; Rastogi N
    FEMS Microbiol Immunol; 1992 Jul; 4(5):281-6. PubMed ID: 1515157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
    Sato K; Tomioka H; Saito H
    Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
    Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
    Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
    Bermudez LE
    J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway delivery of interferon-γ overexpressing macrophages confers resistance to Mycobacterium avium infection in SCID mice.
    Pasula R; Britigan BE; Kesavalu B; Abdalla MY; Martin WJ
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27856731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).
    Sato K; Akaki T; Tomioka H
    Clin Exp Immunol; 1998 Apr; 112(1):63-8. PubMed ID: 9566791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.
    Eriks IS; Emerson CL
    Infect Immun; 1997 Jun; 65(6):2100-6. PubMed ID: 9169738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
    Denis M
    Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.
    Sarmento A; Appelberg R
    Infect Immun; 1996 Aug; 64(8):3224-30. PubMed ID: 8757857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional effects of IFN-gamma on growth of Mycobacterium avium complex in murine peritoneal macrophages.
    Gomez-Flores R; Tamez-Guerra R; Tucker SD; Mehta RT
    J Interferon Cytokine Res; 1997 Jun; 17(6):331-6. PubMed ID: 9198000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation.
    Appelberg R; Orme IM; Pinto de Sousa MI; Silva MT
    Immunology; 1992 Aug; 76(4):553-9. PubMed ID: 1328038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
    Tomioka H; Maw WW; Sato K; Saito H
    Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.
    Bermudez LE; Wu M; Young LS
    Infect Immun; 1995 Oct; 63(10):4099-104. PubMed ID: 7558325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
    Denis M
    Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.